Cancer Biomarkers · 2019 · 32 citations · 34 references
MedicineMolecular BiologyOncologyGene ExpressionMolecular OncologyTumor ProgressionCancer BiomarkersCancer ProgressionLung CancerMalignant NeoplasmsMicrorna BiologyNoncoding Rna In CancerKaplan-meier Survival EstimatesLung Cancer StagingLymph Node Metastasis AssessmentMicrorna Function In CancerMicrorna In CancerMicrorna Prognostic MarkersMicrorna Regulation In CancerPrognostic Biomarkers
BACKGROUND: MicroRNA-425-5p (miR-425-5p) has been investigated in some human cancers, but the understanding of its clinical and functional roles in non-small cell lung cancer (NSCLC) remains poor. OBJECTIVE: This study sought to measure the expression of miR-425-5p in NSCLC samples, assess its prognostic significance in cancer patients, and explore its functional role during tumor progression. METHODS: Expression of miR-425-5p was examined using quantitative Real-time polymerase chain reaction (qRT-PCR). Kaplan-Meier survival analysis and Cox analysis were conducted to evaluate the prognostic value of miR-425-5p. The effects of miR-425-5p on NSCLC cell proliferation, migration and invasion were assessed using cell experiments. RESULTS: Expression of miR-425-5p was upregulated in NSCLC tissues and cells compared with the normal controls (all P< 0.05). The increased miR-425-5p expression was associated with positive lymph node metastasis and TNM advanced stage of the patients (all P< 0.05). The survival curves and Cox analysis indicated that high miR-425-5p was correlated with poor overall survival and acted as an independent prognostic factor in NSCLC patients. Cell experiments suggested that miR-425-5p overexpression could enhance, whereas its reduction could suppress NSCLC cell proliferation, migration and invasion (all P< 0.05). Forhead box J3 (FOXJ3) was proved to be a direct target of miR-425-5p in NSCLC. CONCLUSIONS: Overexpression of miR-425-5p predicts poor prognosis of NSCLC and promotes cancer cell proliferation, migration and invasion by targeting FOXJ3.
34
Global cancer statistics, 2012
Lindsey A. Torre, Freddie Bray, Rebecca L. Siegel et al. · CA A Cancer Journal for Clinicians · 2015 · 27.4K citations · Full text
Xin Zhou, Wei Wen, Xia Shan et al. · Oncotarget · 2016 · 167 citations · Full text
Non-small cell lung cancer and silent brain metastasis
Julio Sánchez de Cos, Michel González, Ma Victoria Montero et al. · Lung Cancer · 2008 · 120 citations
Medicine, Cancer Biology, Oncology +14
MiR-204 inhibits human NSCLC metastasis through suppression of NUAK1
Lihong Shi, B Zhang, Xiuxia Sun et al. · British Journal of Cancer · 2014 · 107 citations · Full text
Medicine, Cancer Biology, Oncology +15